Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOFL in Advanced Pancreatic Adenocarcinoma
NCT00154791Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Mar 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in pancreatic adenocarcinoma (PDAC), sponsored by National Taiwan University Hospital. Started Mar 2003; status: completed.
02
Drugs
oxaliplatin
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00154791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154791.